Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12 Pain, Postoperative 11 Pain 11 Breast Neoplasms 9 Agnosia 9 Depression 8 Head and Neck Neoplasms 6 Chronic Pain 4 Anxiety Disorders 4 Pancreatic Neoplasms 3 Pain, Intractable 3 Colorectal Neoplasms 3 Acute Pain 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Mucositis 2 Gastrointestinal Neoplasms 2 Cancer Pain 2 Stomatitis 1 Spinal Stenosis 1 Rectal Neoplasms 1 Postoperative Analgesia 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Pain, Procedural 1 Otolaryngeal Cancer 1 Neurotoxicity Syndromes 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laparoscopic Colorectal Resection Due to Cancer 1

Interventions

Escitalopram 3 Psilocybin 2 Interpersonal Psychotherapy 2 Infliximab 2 abacavir 1 Vortioxetine 1 Venlafaxine Hydrochloride 1 Transcranial Magnetic Stimulation 1 Sugars 1 Saline Solution 1 Mirtazapine 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Fatty Acids, Omega-3 1 Diagnostic Imaging 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1 Citalopram 1 Bupropion 1 Antidepressive Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Depressive Disorder, Major × Ketamine × Clear all

NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed

Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡